Insulin Aspa Mix 70/30 Inj Sus 10ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin in the upper arm, thigh, buttocks, or stomach area. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Timing of Administration
For individuals with type 1 diabetes, administer this medication within 15 minutes before starting a meal. For those with type 2 diabetes, administer within 15 minutes before or after starting a meal.
Injection Site Selection
Rotate the injection site with each use to avoid injecting into the same area repeatedly. Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
Pre-Administration Checks
Before administering the dose, gently roll the container in your hands as instructed by your doctor. Ensure the solution appears cloudy and milky; do not use if it looks clear or contains lumps. Also, check that no powder is stuck to the sides of the container, the solution is not leaking, and there are no particles present. If the solution has changed color, do not use it.
Disposal of Needles and Containers
Dispose of used needles in a designated needle/sharp disposal box. Do not reuse needles or other items. When the box is full, follow local regulations for proper disposal. If you have any questions, consult your doctor or pharmacist.
Important Administration Guidelines
Do not mix this insulin with other types of insulin in the same syringe. Follow the diet and exercise plan recommended by your doctor, and be aware of the steps to take if you do not eat as usual or skip a meal. This medication is not suitable for use in an insulin pump; if you have questions, consult your doctor. Additionally, do not draw the medication into a syringe and store it for future use.
Storage and Disposal
Store unopened containers in the refrigerator, but do not freeze. If the medication has been frozen, do not use it.
Missed Dose
If you forget to take a dose, be aware of the steps to take. If you are unsure, contact your doctor for guidance.
Lifestyle & Tips
- Always follow your healthcare provider's instructions for diet and exercise.
- Monitor your blood sugar levels regularly as instructed.
- Learn how to recognize and treat low blood sugar (hypoglycemia).
- Carry a source of fast-acting sugar (e.g., glucose tablets, juice) with you at all times.
- Never share insulin pens or syringes with others, even if the needle is changed.
- Rotate injection sites to prevent skin problems (e.g., lipodystrophy).
- Store unopened vials in the refrigerator (36°F-46°F [2°C-8°C]). Once opened, store at room temperature (below 86°F [30°C]) for up to 28 days. Do not freeze.
- Do not use if the suspension appears clear, contains solid particles, or is discolored.
Available Forms & Alternatives
Available Strengths:
- Insulin Aspart 100/ml Inj,10ml
- Insulin Aspa Mix 70/30 Inj Sus 10ml
- Insulin Aspart Penfill Inj, 3ml
- Insulin Aspart Flexpen Inj, 3ml
- Insulin Aspa Mix 70/30 Flexpen, 3ml
- Insulin Lispro Junior Kwikpen 5x3ml
- Insulin Lispro Prt Mix 75/25kwikpen
- Insulin Lispro 100u/ml Vial 10ml
- Insulin Lispro 100u/ml Kwikpen 3ml
- Insulin Glarg-Yfgn 100u/ml Sol 10ml
- Insulin Glarg-Yfgn 100u/ml Pen Inj
- Insulin Glarg Solostar Pen Inj 3ml
- Insulin Glargine 100u/ml, 10ml
- Insulin Degludec U100 Inj Vial 10ml
- Insuln Glargne Solstr U300 PN 1.5ml
- Insulin Glarg U300 Max Solstr Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Some allergic reactions can be life-threatening.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An abnormal heartbeat
Unusual burning, numbness, or tingling sensations
Swelling in the arms or legs
Thick skin, pits, or lumps at the injection site
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures
If you experience any of these symptoms, contact your doctor right away. If you have low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Headache
Back pain
Stomach pain or diarrhea
Heartburn
Weight gain
Irritation at the injection site
Flu-like symptoms
* Common cold symptoms
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat. If these occur, treat immediately with fast-acting sugar.
- Symptoms of high blood sugar (hyperglycemia): increased thirst, frequent urination, fatigue, blurred vision, weight loss. Report persistent high blood sugar to your doctor.
- Symptoms of allergic reaction: rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing. Seek immediate medical attention.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Acidic blood problems
+ Low blood sugar
This list is not exhaustive, and it is crucial to discuss all your health problems with your doctor.
Additionally, provide your doctor and pharmacist with a comprehensive list of all the medications you are taking, including:
Prescription medications
Over-the-counter (OTC) medications
Natural products
Vitamins
This information will help your doctor determine if it is safe for you to take this medication with your existing medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Low blood sugar (hypoglycemia) is a potential side effect of this drug, and severe cases can lead to seizures, loss of consciousness, permanent brain damage, and even death. It is crucial to discuss this risk with your doctor. Additionally, this medication may cause low blood potassium (hypokalemia), which, if left untreated, can result in abnormal heart rhythms, severe breathing difficulties, and potentially death. If you experience any symptoms, consult your doctor promptly.
Until you understand how this medication affects you, avoid driving and other activities that require your full attention. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure or worsen existing heart failure, particularly when used in combination with insulin. If you are taking one of these medications, discuss this risk with your doctor.
Ensure you have the correct insulin product and are familiar with its administration. Insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns about measuring or preparing your dose, consult your doctor or pharmacist.
Stressful events, such as fever, infection, injury, or surgery, can make it more challenging to control your blood sugar levels. Changes in physical activity, exercise, or diet can also impact your blood sugar control.
Wear a medical alert identification (ID) to inform others of your condition in case of an emergency. Avoid driving if you have experienced low blood sugar, as it increases the risk of accidents. Monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as scheduled.
Before consuming alcohol or using products containing alcohol, consult your doctor to discuss potential risks. Never share your insulin product, including pens, cartridge devices, needles, or syringes, with others, even if the needle has been changed, as this can transmit infections.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the benefits and risks of this medication for both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (very low blood sugar)
- Confusion
- Seizures
- Loss of consciousness
- Hypokalemia (low potassium levels)
What to Do:
Immediately consume fast-acting carbohydrates (e.g., glucose tablets, juice, candy). For severe hypoglycemia with unconsciousness, administer glucagon injection and seek emergency medical attention. Call 911 or 1-800-222-1222 (Poison Control).
Drug Interactions
Major Interactions
Moderate Interactions
- Oral antidiabetic agents (increased risk of hypoglycemia)
- ACE inhibitors (may enhance insulin's glucose-lowering effect)
- Angiotensin receptor blockers (ARBs) (may enhance insulin's glucose-lowering effect)
- Salicylates (e.g., aspirin) (may enhance insulin's glucose-lowering effect)
- Sulfonamide antibiotics (may enhance insulin's glucose-lowering effect)
- Monoamine oxidase inhibitors (MAOIs) (may enhance insulin's glucose-lowering effect)
- Corticosteroids (may decrease insulin's glucose-lowering effect)
- Diuretics (e.g., thiazides, loop diuretics) (may decrease insulin's glucose-lowering effect)
- Sympathomimetics (e.g., epinephrine, albuterol) (may decrease insulin's glucose-lowering effect)
- Atypical antipsychotics (e.g., olanzapine, clozapine) (may decrease insulin's glucose-lowering effect)
- Growth hormone (may decrease insulin's glucose-lowering effect)
- Danazol (may decrease insulin's glucose-lowering effect)
- Somatostatin analogs (e.g., octreotide, lanreotide) (may increase or decrease insulin requirements)
- Pentamidine (may cause hypoglycemia followed by hyperglycemia)
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and guide initial dosing.
Timing: Prior to initiation of therapy
Rationale: To establish baseline glucose levels.
Timing: Prior to initiation of therapy
Rationale: To assess kidney function, as insulin clearance is primarily renal and impairment increases hypoglycemia risk.
Timing: Prior to initiation of therapy
Rationale: To assess liver function, as hepatic impairment can affect glucose production and insulin sensitivity.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Multiple times daily (e.g., pre-meal, 2-hour post-meal, bedtime, overnight) depending on patient needs and glycemic control.
Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL post-meal.
Action Threshold: Hypoglycemia (<70 mg/dL): Treat immediately. Hyperglycemia (>180-250 mg/dL): Consider dose adjustment or additional insulin as per care plan.
Frequency: Every 3-6 months (more frequently if glycemic control is suboptimal or therapy is changed).
Target: Individualized, typically <7% for most adults.
Action Threshold: >7% (or individualized target): Re-evaluate treatment regimen, diet, and exercise.
Frequency: Daily, ongoing patient education.
Target: N/A
Action Threshold: Any symptoms (e.g., sweating, tremor, confusion, hunger): Check blood glucose and treat immediately.
Frequency: Daily, ongoing patient education.
Target: N/A
Action Threshold: Any symptoms (e.g., polyuria, polydipsia, fatigue): Check blood glucose, consider dose adjustment, and seek medical advice if severe or persistent.
Symptom Monitoring
- Symptoms of hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat, anxiety, weakness, slurred speech, seizures, unconsciousness.
- Symptoms of hyperglycemia: increased thirst (polydipsia), increased urination (polyuria), increased hunger (polyphagia), fatigue, blurred vision, weight loss, dry skin, slow-healing sores, recurrent infections.
Special Patient Groups
Pregnancy
Insulin is the preferred treatment for diabetes in pregnancy. Well-controlled diabetes is crucial to reduce risks to both mother and fetus. Insulin aspart is generally considered safe and effective during pregnancy. Close monitoring of blood glucose is essential, and insulin requirements may change throughout pregnancy.
Trimester-Specific Risks:
Lactation
Insulin is compatible with breastfeeding. Insulin is a large protein molecule and is not excreted into breast milk in clinically significant amounts. It is considered safe for the nursing infant. Insulin requirements may change during lactation.
Pediatric Use
Dosing must be highly individualized and carefully monitored due to varying insulin sensitivity, growth spurts, and risk of hypoglycemia. Education of parents/caregivers is crucial. Insulin aspart mix 70/30 is approved for use in children 10 years and older with diabetes mellitus.
Geriatric Use
Increased risk of hypoglycemia due to potential for impaired renal/hepatic function, reduced counter-regulatory responses, and polypharmacy. Dosing should be conservative, and blood glucose targets may be less stringent to avoid severe hypoglycemia. Careful monitoring and patient education are essential.
Clinical Information
Clinical Pearls
- Always ensure the patient understands the difference between rapid-acting and intermediate-acting insulin components and the importance of timing injections relative to meals.
- Educate patients on proper mixing technique for vials (gently roll between palms) to ensure uniform suspension before injection.
- Stress the importance of rotating injection sites to prevent lipodystrophy (fat accumulation or atrophy) which can affect insulin absorption.
- Remind patients that insulin requirements can change due to illness, stress, changes in diet or exercise, and other medications.
- Emphasize the critical need for immediate treatment of hypoglycemia and recognition of its symptoms.
Alternative Therapies
- Basal-bolus insulin regimens (e.g., long-acting insulin + rapid-acting insulin before meals)
- Basal insulin only (e.g., insulin glargine, insulin detemir, insulin degludec)
- Oral antidiabetic agents (for Type 2 Diabetes, often in combination with insulin)
- GLP-1 receptor agonists (for Type 2 Diabetes, often in combination with insulin)